Home > Financial Ratios > AUROBINDO PHARMA

AUROBINDO PHARMA
Working Capital/Sales

    Back to All Ratios
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 5.095.175.104.845.35

What is the latest Working Capital/Sales ratio of AUROBINDO PHARMA ?

The latest Working Capital/Sales ratio of AUROBINDO PHARMA is 5.09 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20255.09
Mar20245.17
Mar20235.10
Mar20224.84
Mar20215.35

How is Working Capital/Sales of AUROBINDO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 5.09
-1.55
Mar2024 5.17
1.37
Mar2023 5.1
5.37
Mar2022 4.84
-9.53
Mar2021 5.35 -

Other Financial Ratios of AUROBINDO PHARMA


Compare Working Capital/Sales ratio of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹70,430.7 Cr 0.2% 0.4% -1.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹416,884.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹172,442.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,770.0 Cr 1.3% 2.7% 10% Stock Analytics
CIPLA ₹120,871.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,693.0 Cr -1% 2.5% -4.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

0.2%

0.4%

-1.9%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses